Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

   < < Go Back
from The New York Times,

Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.

More From The New York Times (subscription required):